Cdc2L5 Antibodies

Santa Cruz Biotechnology features a diverse variety of Cdc2L5 monoclonal antibodies for research in cell cycle regulation and mitotic processes. Cdc2L5 monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cdc2L5, also known as cyclin-dependent kinase 11 (CDK11), plays a crucial role in regulating the cell cycle and is involved in processes such as RNA splicing and transcription. Proper Cdc2L5 function is essential for maintaining cellular homeostasis and ensuring accurate cell division. Dysregulation of Cdc2L5 has been implicated in various diseases, including cancer, making it a significant target for therapeutic research. Understanding Cdc2L5's molecular mechanisms can provide valuable insights into cell cycle control and disease development. Research utilizing Cdc2L5 monoclonal antibodies continues to reveal new aspects of cellular regulation and signaling pathways. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of cell cycle regulation and its impact on human health.